Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Commentary re: N. J. McCarthy et al., microvessel density, expression of estrogen receptor alpha, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clin. Cancer Res., 8: 3857-3862, 2002
Cecile G Colpaert, Peter B Vermeulen, Luc Y Dirix, et al.
Gynecologic Oncology
|
January 31, 2004
Sentinel node detection in patients with vaginal carcinoma
Peter van Dam, Hetty Sonnemans, Pieter-Jan van Dam, et al.
Clinical Breast Cancer
|
March 20, 2002
Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients
Ina Benoy, Roberto Salgado, Cecile Colpaert, et al.
Gynecologic Oncology
|
September 10, 2002
Sentinel node metastasis in the groin detected by technetium-labeled nannocolloid in a patient with cervical cancer
Jan Hauspy, Luc Verkinderen, Christel De Pooter, et al.
Cancer
|
May 27, 2010
Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments
Steven Van Laere, Ridha Limame, Eric A Van Marck, et al.
Journal of the National Cancer Institute
|
June 11, 2009
Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
Steven J Van Laere, Hilde Elst, Dieter Peeters, et al.
Breast Cancer Research : BCR
|
April 8, 2015
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
Eleni van Schooneveld, Hans Wildiers, Ignace Vergote, et al.
Expert Opinion on Investigational Drugs
|
November 6, 2009
The rationale for mTOR inhibition in epithelial ovarian cancer
Xuan Bich Trinh, Peter A van Dam, Luc Y Dirix, et al.
Breast Cancer Research and Treatment
|
October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis
Cecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
International Journal of Cancer
|
December 21, 2002
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
Roberto Salgado, Sara Junius, Ina Benoy, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Commentary re: N. J. McCarthy et al., microvessel density, expression of estrogen receptor alpha, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clin. Cancer Res., 8: 3857-3862, 2002
Cecile G Colpaert, Peter B Vermeulen, Luc Y Dirix, et al.
Gynecologic Oncology
|
January 31, 2004
Sentinel node detection in patients with vaginal carcinoma
Peter van Dam, Hetty Sonnemans, Pieter-Jan van Dam, et al.
Clinical Breast Cancer
|
March 20, 2002
Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients
Ina Benoy, Roberto Salgado, Cecile Colpaert, et al.
Gynecologic Oncology
|
September 10, 2002
Sentinel node metastasis in the groin detected by technetium-labeled nannocolloid in a patient with cervical cancer
Jan Hauspy, Luc Verkinderen, Christel De Pooter, et al.
Cancer
|
May 27, 2010
Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments
Steven Van Laere, Ridha Limame, Eric A Van Marck, et al.
Journal of the National Cancer Institute
|
June 11, 2009
Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
Steven J Van Laere, Hilde Elst, Dieter Peeters, et al.
Breast Cancer Research : BCR
|
April 8, 2015
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
Eleni van Schooneveld, Hans Wildiers, Ignace Vergote, et al.
Expert Opinion on Investigational Drugs
|
November 6, 2009
The rationale for mTOR inhibition in epithelial ovarian cancer
Xuan Bich Trinh, Peter A van Dam, Luc Y Dirix, et al.
Breast Cancer Research and Treatment
|
October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis
Cecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
International Journal of Cancer
|
December 21, 2002
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
Roberto Salgado, Sara Junius, Ina Benoy, et al.
Page
of 9